As noted above, among all of the Brugada syndrome causative genes, SCN5A, which includes hundreds of associated mutations, accounts for about 20%-30% of the Brugada syndrome clinical phenotypes, while mutations in the other 6 recently identified related mutant genes only account for one family or a very small number of Brugada syndrome phenotypes. This evidence concerns the gene SCN5A and Brugada syndrome.